BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38754869)

  • 61. Misspecification of confounder-exposure and confounder-outcome associations leads to bias in effect estimates.
    Schuster NA; Rijnhart JJM; Bosman LC; Twisk JWR; Klausch T; Heymans MW
    BMC Med Res Methodol; 2023 Jan; 23(1):11. PubMed ID: 36635655
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The role of quantitative bias analysis for nonrandomized comparisons in health technology assessment: recommendations from an expert workshop.
    Leahy TP; Durand-Zaleski I; Sampietro-Colom L; Kent S; Zöllner Y; Coyle D; Casadei G
    Int J Technol Assess Health Care; 2023 Nov; 39(1):e68. PubMed ID: 37981828
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Quantitative bias analysis for study and grant planning.
    Fox MP; Lash TL
    Ann Epidemiol; 2020 Mar; 43():32-36. PubMed ID: 32113733
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Importance of Making Assumptions in Bias Analysis.
    MacLehose RF; Ahern TP; Lash TL; Poole C; Greenland S
    Epidemiology; 2021 Sep; 32(5):617-624. PubMed ID: 34224472
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Noncollapsibility and its role in quantifying confounding bias in logistic regression.
    Schuster NA; Twisk JWR; Ter Riet G; Heymans MW; Rijnhart JJM
    BMC Med Res Methodol; 2021 Jul; 21(1):136. PubMed ID: 34225653
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Addressing unmeasured confounding in comparative observational research.
    Zhang X; Faries DE; Li H; Stamey JD; Imbens GW
    Pharmacoepidemiol Drug Saf; 2018 Apr; 27(4):373-382. PubMed ID: 29383840
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Amplification of Bias Due to Exposure Measurement Error.
    Richardson DB; Keil AP; Cole SR
    Am J Epidemiol; 2022 Jan; 191(1):182-187. PubMed ID: 34455433
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Assessing the impact of unmeasured confounders for credible and reliable real-world evidence.
    Zhang X; Stamey JD; Mathur MB
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1219-1227. PubMed ID: 32929830
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A descriptive review of variable selection methods in four epidemiologic journals: there is still room for improvement.
    Talbot D; Massamba VK
    Eur J Epidemiol; 2019 Aug; 34(8):725-730. PubMed ID: 31161279
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Brief Report: Negative Controls to Detect Selection Bias and Measurement Bias in Epidemiologic Studies.
    Arnold BF; Ercumen A; Benjamin-Chung J; Colford JM
    Epidemiology; 2016 Sep; 27(5):637-41. PubMed ID: 27182642
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A comparison of methods to estimate the survivor average causal effect in the presence of missing data: a simulation study.
    McGuinness MB; Kasza J; Karahalios A; Guymer RH; Finger RP; Simpson JA
    BMC Med Res Methodol; 2019 Dec; 19(1):223. PubMed ID: 31795945
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adjusting for unmeasured confounding in nonrandomized longitudinal studies: a methodological review.
    Streeter AJ; Lin NX; Crathorne L; Haasova M; Hyde C; Melzer D; Henley WE
    J Clin Epidemiol; 2017 Jul; 87():23-34. PubMed ID: 28460857
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Machine learning for improving high-dimensional proxy confounder adjustment in healthcare database studies: An overview of the current literature.
    Wyss R; Yanover C; El-Hay T; Bennett D; Platt RW; Zullo AR; Sari G; Wen X; Ye Y; Yuan H; Gokhale M; Patorno E; Lin KJ
    Pharmacoepidemiol Drug Saf; 2022 Sep; 31(9):932-943. PubMed ID: 35729705
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The missing cause approach to unmeasured confounding in pharmacoepidemiology.
    Abrahamowicz M; Bjerre LM; Beauchamp ME; LeLorier J; Burne R
    Stat Med; 2016 Mar; 35(7):1001-16. PubMed ID: 26932124
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluating epidemiologic evidence of the effects of food and nutrient exposures.
    Flegal KM
    Am J Clin Nutr; 1999 Jun; 69(6):1339S-1344S. PubMed ID: 10359234
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bias Reduction through Analysis of Competing Events (BRACE) Correction to Address Cancer Treatment Selection Bias in Observational Data.
    Williamson CW; Nelson TJ; Thompson CA; Vitzthum LK; Zakeri K; Riviere PJ; Bryant AK; Sharabi AB; Zou J; Mell LK
    Clin Cancer Res; 2022 May; 28(9):1832-1840. PubMed ID: 35140122
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Model specification and unmeasured confounders in partially ecologic analyses based on group proportions of exposed.
    Björk J; Strömberg U
    Scand J Work Environ Health; 2005 Jun; 31(3):184-90. PubMed ID: 15999570
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bias Amplification in Epidemiologic Analysis of Exposure to Mixtures.
    Weisskopf MG; Seals RM; Webster TF
    Environ Health Perspect; 2018 Apr; 126(4):047003. PubMed ID: 29624292
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Fixed effects analysis of repeated measures data.
    Gunasekara FI; Richardson K; Carter K; Blakely T
    Int J Epidemiol; 2014 Feb; 43(1):264-9. PubMed ID: 24366487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.